Literature DB >> 8474014

Epidermal growth factor and transforming growth factor-alpha directly inhibit parietal cell function through a similar mechanism.

L Wang1, M R Lucey, A M Fras, E J Wilson, J Del Valle.   

Abstract

Epidermal growth factor (EGF) and transforming growth factor-alpha (TGF-alpha) are naturally occurring peptides which are present throughout the gastrointestinal tract and are capable of inhibiting gastric acid secretion. Although previous studies have suggested that TGF-alpha may serve as an autocrine factor regulating parietal cell function, the cellular mechanisms by which it exerts its inhibitory action have not been fully elucidated. In addition, no systematic comparison has been undertaken of the effects of EGF and TGF-alpha on parietal cell function. The aims of the present studies were to compare the actions of EGF and TGF-alpha on basal and stimulated acid secretion by isolated rabbit parietal cells and to elucidate the intracellular mechanisms by which these growth factors inhibit acid secretion stimulated by agents that activate the adenylate cyclase and cyclic AMP second messenger system. Although EGF and TGF-alpha did not alter basal parietal cell function, they both inhibited histamine-stimulated [14C]aminopyrine accumulation in a identical time- and dose-dependent fashion. The maximal effect of approximately 40% inhibition for histamine-stimulated action was achieved with concentrations of 10(-6) M for both EGF and TGF-alpha. The inhibitory effect of EGF and TGF-alpha appeared to be at the postreceptor level as neither growth factor significantly altered binding of histamine to its receptor (H2) on parietal cells. Consistent with this postulated mechanism of action, both EGF and TGF-alpha dose-dependently inhibited forskolin-stimulated aminopyrine uptake with IC50 similar to those required for inhibiting the stimulatory effect of histamine. Of note, neither growth factor inhibited parietal cell activity stimulated by dibutyryl cyclic AMP.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8474014

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  8 in total

1.  Effects of pro-inflammatory cytokines on acid secretion.

Authors:  I L Beales
Journal:  Dig Dis Sci       Date:  2000-02       Impact factor: 3.199

2.  Inhibition of carbachol stimulated acid secretion by interleukin 1beta in rabbit parietal cells requires protein kinase C.

Authors:  I L Beales; J Calam
Journal:  Gut       Date:  2001-06       Impact factor: 23.059

3.  EGF receptor activation stimulates endogenous gastrin gene expression in canine G cells and human gastric cell cultures.

Authors:  M G Ford; J D Valle; C J Soroka; J L Merchant
Journal:  J Clin Invest       Date:  1997-06-01       Impact factor: 14.808

4.  Effect of N alpha-methyl-histamine on acid secretion in isolated cultured rabbit parietal cells: implications for Helicobacter pylori associated gastritis and gastric physiology.

Authors:  I L Beales; J Calam
Journal:  Gut       Date:  1997-01       Impact factor: 23.059

5.  Immunolocalization of transforming growth factor-alpha and epidermal growth factor receptor in the rat gastroduodenal area.

Authors:  B Montaner; M Asbert; R Pérez-Tomás
Journal:  Dig Dis Sci       Date:  1999-07       Impact factor: 3.199

6.  Interleukin 1 beta and tumour necrosis factor alpha inhibit acid secretion in cultured rabbit parietal cells by multiple pathways.

Authors:  I L Beales; J Calam
Journal:  Gut       Date:  1998-02       Impact factor: 23.059

7.  Comparison of the antisecretory and antiulcer activity of epidermal growth factor, urogastrone and transforming growth factor alpha and its derivative in rodents in vivo.

Authors:  S M A Bastaki; S I Chandranath; J Singh
Journal:  Mol Cell Biochem       Date:  2002-07       Impact factor: 3.396

Review 8.  The Physiology of the Gastric Parietal Cell.

Authors:  Amy C Engevik; Izumi Kaji; James R Goldenring
Journal:  Physiol Rev       Date:  2019-10-31       Impact factor: 37.312

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.